FreshLeaf Analytics

FreshLeaf Analytics H1 Report Predicts Cannabis Industry Revenue Will Reach $200 Million in 2021

However, the report cautioned that Australia may be in danger of potentially losing a billion-dollar industry if the medicinal cannabis market is not adequately regulated.Earlier t...

FreshLeaf Analytics Discusses the Legalization of Over-The-Counter CBD in Australia

With a clear path towards CBD product registration now in place, cannabis companies are racing to get products on the shelves as quickly as possible.Welcome to the fourteenth episo...

TGA Issues Final Ruling on Over-the-Counter CBD and Increases Daily Dosage Limit

Australian pot stocks now have a clear path towards CBD product registration, unlocking a market worth more than $200 million.Earlier today the Therapeutic Goods Administration (TG...

The Australian Government May Soon Allow Over-The-Counter CBD Sales

FreshLeafAnalytics discovered evidence of the "watershed move" in a submission to theSenate Inquiry into improving patient access to medicinal cannabis. According to FreshLeaf Anal...

Australian Government Legalizes Over-The-Counter CBD

The rescheduling will be limited to oral, mucosal and sublingual CBD products, which means that vaping, topical creams and smokables will remain illegal.Earlier today the Australia...

TGA Approves Record Breaking Number of Australian Medicinal Cannabis Patients

As a result, the overall number of approved applications for medicinal cannabis products has climbed to approximately 67,000.The Therapeutic Goods Administration (TGA) approved a r...

Australian Cannabis Companies Fail TGA Testing Requirements

The affected companies have pledged to resolve the inconsistencies, which were uncovered as part of routine surveillance conducted by the TGA.The Therapeutic Goods Administration (...

FreshLeaf Analytics Q3 Cannabis Report Reveals Biggest Price Drop Since 2016

Cannabis industry revenue is also expected to triple during 2020—growing to approximately $95 million—while active patient numbers are on schedule to reach 30,000 before the ye...

TGA Announces Delay to Decision on Epidyolex Subsidies

However, the PBAC's decision was "a deferment, not a rejection", according to a statement from FreshLeaf Analytics. The Pharmaceutical Benefits Advisory Committee (PBAC) has offici...

FreshLeaf Analytics Strengthens Management Team with Innovation Specialist Cassandra Hunt

Cassandra will be joining the company as Managing Director, while also sitting on FreshLeaf Analytics' advisory board. There was big news from FreshLeaf Analytics—which operatesa...